Emotion regulation across eating pathology: A meta-analysis.
Alice-Beatrice Prefit, Diana Mirela Cândea, Aurora Szentagotai-Tătar
https://pubmed.ncbi.nlm.nih.gov/31479694/Actively Recruiting
Led by Uppsala University Hospital · Updated on 2025-01-24
18
Participants Needed
1
Research Sites
30 weeks
Total Duration
Researchers are evaluating Radically Open Dialectical Behavior Therapy RO-DBT for adolescents aged 14 to 19 who have eating disorders with emotional overcontrol and have not fully responded to previous treatments. This study focuses on whether RO-DBT is feasible to provide and if it can reduce eating disorder symptoms and related emotional difficulties. The trial aims to help those at risk of developing severe and enduring eating disorders by targeting emotional overcontrol, a key factor in restrictive eating disorders. The treatment consists of approximately 22 weeks of RO-DBT, including individual psychotherapy and parallel group skills training. A parent group with four sessions is also included to support the adolescent participants. The study uses a single-case experimental design with multiple baselines, where each participant serves as their own control. Participants are randomly assigned to different baseline lengths of 4 to 6 weeks before starting treatment, followed by weekly assessments during the treatment period. Participants will attend weekly therapy sessions and complete questionnaires measuring eating disorder symptoms, body mass index, emotional regulation, loneliness, social functioning, anxiety, and depression. Assessments occur weekly during baseline and treatment phases, plus follow-ups six months and one year after treatment ends. Researchers will also evaluate treatment feasibility by tracking attendance, homework completion, and participant feedback. This process includes interviews post-treatment to capture participant experiences and ongoing safety monitoring.
CONDITIONS
Evaluation of Radically Open Dialectical Behavior Therapy for Youth At Risk for Developing Severe and Enduring Eating Disorders
M
Martina Isaksson, PhD
M
Mia Ramklint, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Uppsala University Hospital
Lead Sponsor
Forskningsrådet för hälsa, arbetsliv och välfärd (FORTE)
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person) for information and evaluation sessions
Duration - 4 to 6 weeks
Participants complete weekly assessments while not receiving treatment to establish baseline measures.
Weekly visits for assessments
Duration - Approximately 22 weeks
Participants receive Radically Open Dialectical Behavior Therapy (RO-DBT) consisting of individual therapy and group skills training, along with a parent group.
Weekly visits for individual therapy and skills training sessions
Duration - 1 year after treatment completion
Participants are followed up one year after treatment to assess the lasting effects of the therapy.
1 follow-up visit
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Alice-Beatrice Prefit, Diana Mirela Cândea, Aurora Szentagotai-Tătar
https://pubmed.ncbi.nlm.nih.gov/31479694/Martina Isaksson, Ata Ghaderi, Mia Ramklint...
https://pubmed.ncbi.nlm.nih.gov/33524917/Pamela K Keel, Tiffany A Brown
https://pubmed.ncbi.nlm.nih.gov/20186717/Anna Oldershaw, Tony Lavender, Hannah Sallis...
https://pubmed.ncbi.nlm.nih.gov/26043394/Janet Treasure, Tiago Antunes Duarte, Ulrike Schmidt
https://pubmed.ncbi.nlm.nih.gov/32171414/Martina Isaksson, Ata Ghaderi, Martina Wolf-Arehult...
https://pubmed.ncbi.nlm.nih.gov/33663612/Julian Baudinet, Mima Simic, Helena Griffiths...
https://pubmed.ncbi.nlm.nih.gov/33292696/Martina Isaksson, Ata Ghaderi, Martina Wolf-Arehult...
https://pubmed.ncbi.nlm.nih.gov/33863394/Elisabet Wentz, I Carina Gillberg, Henrik Anckarsäter...
https://pubmed.ncbi.nlm.nih.gov/19182181/Uppsala University Hospital
Lead Sponsor
Forskningsrådet för hälsa, arbetsliv och välfärd (FORTE)
Collaborating Sponsor